Maravai LifeSciences(MRVI) Seeking Alpha·2025-03-21 01:00Group 1 - Maravai LifeSciences Holdings, Inc. held its Q4 2024 earnings conference call on March 20, 2025, with key participants including CEO Trey Martin and CFO Kevin Herde [1][3] - The call included a formal presentation followed by a question and answer session, indicating an interactive format for discussing financial results [2][3] - The agenda for the call was outlined in the presentation slides, which were made available on the company's investor relations website [3] Group 2 - Management indicated that forward-looking statements would be made during the call, along with references to both GAAP and non-GAAP financial measures [4] - The company provided reconciliations to the most directly comparable GAAP measures in their press release and on their investor website [4]